149 related articles for article (PubMed ID: 26451909)
41. [The study of CD90 expressing in orbital fibroblasts of thyroid associated ophthalmopathy].
Tang L; Luo QL; Xia QJ; Chen QY; Liu CL; Tang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):879-81. PubMed ID: 17243294
[TBL] [Abstract][Full Text] [Related]
42. Elevated bone morphogenic protein 4 expression implicated in site-specific adipogenesis in thyroid associated orbitopathy.
Wong JSC; Chu WK; Li BFL; Zhang BN; Pang CP; Chong KKL
Exp Eye Res; 2019 Apr; 181():185-189. PubMed ID: 30721670
[TBL] [Abstract][Full Text] [Related]
43. Effect of Prunella vulgaris polysaccharides on cultured orbit fibroblasts in vitro from patients with thyroid-associated ophthalmopathy.
Li B; Guo J; Wang F; Cheng S; Zeng L
Exp Eye Res; 2020 Dec; 201():108276. PubMed ID: 32991886
[TBL] [Abstract][Full Text] [Related]
44. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy.
Byun JS; Moon NJ; Lee JK
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):413-420. PubMed ID: 27838736
[TBL] [Abstract][Full Text] [Related]
45. [The pathological changes of the orbital tissue in thyroid associated ophthalmopathy].
Hei Y; Kang L; Li YY; Xiao LH
Zhonghua Yan Ke Za Zhi; 2008 May; 44(5):423-6. PubMed ID: 18953897
[TBL] [Abstract][Full Text] [Related]
46. The Pro 12 Ala PPAR gamma gene polymorphism: possible modifier of the activity and severity of thyroid-associated orbitopathy (TAO).
Alevizaki M; Mantzou E; Cimponeriu A; Saltiki K; Philippou G; Wiersinga W
Clin Endocrinol (Oxf); 2009 Mar; 70(3):464-8. PubMed ID: 18624999
[TBL] [Abstract][Full Text] [Related]
47. Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates.
Salvi M; Vannucchi G; Campi I; Currò N; Simonetta S; Covelli D; Pignataro L; Guastella C; Rossi S; Bonara P; Dazzi D; Ratiglia R; Beck-Peccoz P
Clin Immunol; 2009 May; 131(2):360-5. PubMed ID: 19195932
[TBL] [Abstract][Full Text] [Related]
48. Prevalence, Phenotype, and Psychosocial Well-Being in Euthyroid/Hypothyroid Thyroid-Associated Orbitopathy.
Ponto KA; Binder H; Diana T; Matheis N; Otto AF; Pitz S; Pfeiffer N; Kahaly GJ
Thyroid; 2015 Aug; 25(8):942-8. PubMed ID: 26244413
[TBL] [Abstract][Full Text] [Related]
49. Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity.
Higashiyama T; Iwasa M; Ohji M
Sci Rep; 2017 Dec; 7(1):16874. PubMed ID: 29203853
[TBL] [Abstract][Full Text] [Related]
50. Lysosome-related genes are regulated in the orbital fat of patients with graves' ophthalmopathy.
Chen MH; Liao SL; Chen MH; Tsou PL; Shih MJ; Chang TC; Chuang LM
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4760-4. PubMed ID: 18552385
[TBL] [Abstract][Full Text] [Related]
51. Differential expression and alternative splicing of transcripts in orbital adipose/connective tissue of thyroid-associated ophthalmopathy.
Wu L; Liang Y; Song N; Wang X; Jiang C; Chen X; Qin B; Sun X; Liu G; Zhao C
Exp Biol Med (Maywood); 2021 Sep; 246(18):1990-2006. PubMed ID: 34078122
[TBL] [Abstract][Full Text] [Related]
52. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs.
Cozma I; Zhang L; Uddin J; Lane C; Rees A; Ludgate M
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1630-5. PubMed ID: 17848636
[TBL] [Abstract][Full Text] [Related]
53. Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy.
Marinò M; Lisi S; Pinchera A; Mazzi B; Latrofa F; Sellari-Franceschini S; McCluskey RT; Chiovato L
Thyroid; 2001 Feb; 11(2):177-85. PubMed ID: 11288989
[TBL] [Abstract][Full Text] [Related]
54. Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy.
Mimura LY; Villares SM; Monteiro ML; Guazzelli IC; Bloise W
Thyroid; 2003 Sep; 13(9):845-50. PubMed ID: 14588098
[TBL] [Abstract][Full Text] [Related]
55. Culture and differentiation of human orbital preadipocytes in thyroid-associated ophthalmopathy.
Wang L; Wu Z; Yan J; Yang H; Chen Z
Yan Ke Xue Bao; 2005 Mar; 21(1):27-30, 37. PubMed ID: 17162913
[TBL] [Abstract][Full Text] [Related]
56. [Cell surface antigen expression of orbital preadipocytes between patients with thyroid-associated ophthalmopathy and healthy adults].
Lei X; Xu XL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):43-6. PubMed ID: 18245903
[TBL] [Abstract][Full Text] [Related]
57. Failure to demonstrate cell-mediated immunity to orbital tissue antigens and epitopic fragments of a 64 kDa protein in the majority of patients with thyroid-associated ophthalmopathy.
Kiljanski J; Stolarski C; Barsouk A; Nebes V; Wall JR
J Endocrinol Invest; 1996 May; 19(5):284-92. PubMed ID: 8796336
[TBL] [Abstract][Full Text] [Related]
58. Thyroid-associated orbitopathy and tears: A proteomics study.
Kishazi E; Dor M; Eperon S; Oberic A; Hamedani M; Turck N
J Proteomics; 2018 Jan; 170():110-116. PubMed ID: 28887209
[TBL] [Abstract][Full Text] [Related]
59. A novel mechanism involved in the pathogenesis of Graves ophthalmopathy (GO): clathrin is a possible targeting molecule for inhibiting local immune response in the orbit.
Meyer zu Hörste M; Ströher E; Berchner-Pfannschmidt U; Schmitz-Spanke S; Pink M; Göthert JR; Fischer JW; Gulbins E; Eckstein AK
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1727-36. PubMed ID: 21917865
[TBL] [Abstract][Full Text] [Related]
60. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
